Search results for "Highlights"
Insulin prices drop, may spur long-term trend
A major manufacturer announced a cut in the prices of its insulins and instituted a $35 out-of-pocket monthly cap for commercially insured patients.
https://diabetes.acponline.org/archives/2023/03/10/1.htm
10 Mar 2023
Fiber-enriched formula linked to improved health-related quality of life, HbA1c in type 2 diabetes
Participants who consumed prebiotic fiber-enriched nutritional shakes had improved measures of health-related quality of life and reduced HbA1c level at 12 weeks compared to those who consumed placebo shakes, an industry-funded trial found.
https://diabetes.acponline.org/archives/2023/01/13/3.htm
13 Jan 2023
Metformin during pregnancy not associated with adiposity in children
A follow-up study of a randomized trial of women with type 2 diabetes during pregnancy found that scores for body mass index were similar up to age 24 months in children who were and were not exposed to metformin in utero.
https://diabetes.acponline.org/archives/2023/02/10/2.htm
10 Feb 2023
HbA1c-based screening of general population reduced time to diabetes diagnosis
In a British database, 1% of participants ages 40 to 70 years had undiagnosed diabetes. Researchers estimated that population-based screening using HbA1c level could have reduced the time to diagnosis in this group by a median of 2.2 years.
https://diabetes.acponline.org/archives/2022/12/09/2.htm
9 Dec 2022
Time-restricted eating may help improve metabolic status
People who time-restricted their eating had decreased body weight and fat mass and improved lipid values but did not show improvements in waist circumference, HbA1c level, or blood pressure, a systematic review and meta-analysis found.
https://diabetes.acponline.org/archives/2022/10/14/2.htm
14 Oct 2022
Annual screening for albuminuria may not be necessary in all patients with type 1 diabetes
A recent study found that personalizing the timing of testing based on patients' albumin excretion rate and HbA1c level could reduce time with undetected kidney disease as well as testing frequency.
https://diabetes.acponline.org/archives/2022/11/11/2.htm
11 Nov 2022
Diabetes and prior CVD may no longer carry equivalent cardiovascular risk
In a population-based Canadian study, the magnitude of the association between diabetes and risk of cardiovascular events decreased while that between cardiovascular disease (CVD) and such events remained stable.
https://diabetes.acponline.org/archives/2022/11/11/3.htm
11 Nov 2022
Patients diagnosed by OGTT without elevated HbA1c had similar CV, renal disease risks as those without diabetes
A prospective U.K. study found that patients with diabetes based on an oral glucose tolerance test (OGTT) often did not have a diabetic HbA1c level, and risks of cardiovascular (CV) and kidney disease in these patients were similar to those in the nondiabetic general population.
https://diabetes.acponline.org/archives/2022/09/16/3.htm
16 Sep 2022
Gestational diabetes associated with risks later in life, but lifestyle makes a difference, studies find
A review found increased risks of cardiovascular and cerebrovascular disease in women who had gestational diabetes, while another study showed that five markers of a healthy lifestyle were associated with a significant reduction in risk of developing type 2 diabetes after gestational diabetes.
https://diabetes.acponline.org/archives/2022/10/14/8.htm
14 Oct 2022
Initiation of glucose-lowering therapies may be associated with reduced physical activity
An analysis of 148 participants from three randomized trials found that starting liraglutide, empagliflozin, or sitagliptin was associated with reduction in physical activity of about 1,000 steps per day or 10 minutes of moderate to vigorous physical activity per day.
https://diabetes.acponline.org/archives/2022/09/16/2.htm
16 Sep 2022